Price T Rowe Associates Inc Horizon Therapeutics Public LTD CO Transaction History

Price T Rowe Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $20.3 Million - $23.7 Million	-205,184 Reduced 61.31%	129,492 $15 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $14 Million - $16.3 Million	-145,327 Reduced 30.28%	334,676 $34.4 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $16.6 Million - $17.6 Million	-155,052 Reduced 24.42%	480,003 $52.4 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $9.65 Million - $17.6 Million	-154,700 Reduced 19.59%	635,055 $72.3 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $95,214 - $136,826	-1,616 Reduced 0.2%	789,755 $48.9 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.96 Million - $2.88 Million	-24,740 Reduced 3.03%	791,371 $63.1 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $2.43 Million - $3.09 Million	-28,106 Reduced 3.33%	816,111 $85.9 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $983,037 - $1.2 Million	-9,974 Reduced 1.17%	844,217 $91 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $5.08 Million - $6.1 Million	-55,275 Reduced 6.08%	854,191 $93.6 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $14.4 Million - $16 Million	-167,237 Reduced 15.53%	909,466 $85.2 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $6.42 Million - $8.53 Million	-89,343 Reduced 7.66%	1,076,703 $99.1 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $78.1 Million - $98.4 Million	1,166,046 New	1,166,046 $85.3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.